Sargassum horneri Extract Alleviates Testosterone-Induced Benign Prostatic Hyperplasia In vitro and In vivo

References

• Afonso NC, Catarino MD, Silva AMS, Cardoso SM. 2019. Brown macroalgae as valuable food ingredients. Antioxidants (Basel). 8(9): 365.
   Google Scholar
• Azzouni F, Mohler J. 2012. Role of 5alpha-reductase inhibitors in benign prostatic diseases. Prostate Cancer Prostatic Dis. 15(3):222–30.
   PubMed Web of Science ®Google Scholar
• Barkin J. 2011. Benign prostatic hyperplasia and lower urinary tract symptoms: Evidence and approaches for best case management. Can J Urol. 18 Suppl:14–19.
   PubMed Web of Science ®Google Scholar
• Barry MJ, Fowler FJ, Jr., O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. 1992. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 148(5):1549–57; discussion 1564.
   PubMed Web of Science ®Google Scholar
• Brown ES, Allsopp PJ, Magee PJ, Gill CI, Nitecki S, Strain CR, McSorley EM. 2014. Seaweed and human health. Nutr Rev. 72(3):205–16.
   PubMed Web of Science ®Google Scholar
• Cao EB. 1999. Zhong Hua Ben Cao (China Herbal). Shanghai: Shanghai Science and Technology Publishing House.
   Google Scholar
• Carson C 3rd, Rittmaster R. 2003. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 61(4 Suppl 1):2–7.
   PubMed Web of Science ®Google Scholar
• Cherry P, O’Hara C, Magee PJ, McSorley EM, Allsopp PJ. 2019. Risks and benefits of consuming edible seaweeds. Nutr Rev. 77(5):307–29.
   PubMed Web of Science ®Google Scholar
• Corona G, Tirabassi G, Santi D, Maseroli E, Gacci M, Dicuio M, Sforza A, Mannucci E, Maggi M. 2017. Sexual dysfunction in subjects treated with inhibitors of 5alpha-reductase for benign prostatic hyperplasia: A comprehensive review and meta-analysis. Andrology. 5(4):671–78.
   PubMed Web of Science ®Google Scholar
• Csikos E, Horvath A, Acs K, Papp N, Balazs VL, Dolenc MS, Kenda M, Kocevar Glavac N, Nagy M, Protti M, et al. 2021. Treatment of benign prostatic hyperplasia by natural drugs. Molecules. 26(23): 7141.
   Web of Science ®Google Scholar
• Dias M, Madusanka DMD, Han EJ, Kim MJ, Jeon YJ, Kim HS, Fernando IPS, Ahn G. 2020. (-)-Loliolide isolated from sargassum horneri protects against fine dust-induced oxidative stress in human keratinocytes. Antioxidants (Basel). 9(6): 474.
   Google Scholar
• Izumi K, Mizokami A, Lin W-J, Lai K-P, Chang C. 2013. Androgen Receptor Roles in the Development of Benign Prostate Hyperplasia, 182(6): 1942–49. doi: 10.1016/j.ajpath.2013.02.028
   Google Scholar
• Jayawardena TU, Asanka Sanjeewa KK, Shanura Fernando IP, Ryu BM, Kang MC, Jee Y, Lee WW, Jeon YJ. 2018. Sargassum horneri (Turner) C. Agardh ethanol extract inhibits the fine dust inflammation response via activating Nrf2/HO-1 signaling in RAW 264.7 cells. BMC Complement Altern Med. 18(1):249.
   PubMedGoogle Scholar
• Kim EH, Brockman JA, Andriole GL. 2018. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Asian J Urol. 5(1):28–32.
   PubMed Web of Science ®Google Scholar
• Kim HS, Wang L, Fernando IPS, Je JG, Ko SC, Kang MC, Lee JM, Yim MJ, Jeon YJ, Lee DS. 2020. Antioxidant efficacy of (-)-loliolide isolated from Sargassum horneri against AAPH-induced oxidative damage in Vero cells and zebrafish models in vivo. J Appl Phycol. 32(5):3341–48.
   Web of Science ®Google Scholar
• Kishida R, Yamagishi K, Muraki I, Sata M, Tamakoshi A, Iso H, Group JS. 2020. Frequency of seaweed intake and its association with cardiovascular disease mortality: the JACC study. J Atheroscler Thromb. 27(12):1340–47.
   PubMed Web of Science ®Google Scholar
• Kubo N, Douke A, Nishigaki T, Tsuji G. 2017. Development and characterization of simple sequence repeat markers for genetic analyses of Sargassum horneri (Sargassaceae, Phaeophyta) populations in Kyoto, Japan. J Appl Phycol. 29(3):1729–33.
   Web of Science ®Google Scholar
• Kyprianou N, Tu H, Jacobs SC. 1996. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol. 27(7):668–75.
   PubMed Web of Science ®Google Scholar
• Liu L, Heinrich M, Myers S, Dworjanyn SA. 2012. Towards a better understanding of medicinal uses of the brown seaweed Sargassum in Traditional Chinese Medicine: A phytochemical and pharmacological review. J Ethnopharmacol. 142(3):591–619.
   PubMed Web of Science ®Google Scholar
• McVary KT. 2006. BPH: Epidemiology and comorbidities. Am J Manag Care. 12(5 Suppl):S122–128.
   PubMed Web of Science ®Google Scholar
• Murai U, Yamagishi K, Sata M, Kokubo Y, Saito I, Yatsuya H, Ishihara J, Inoue M, Sawada N, Iso H, et al. 2019. Seaweed intake and risk of cardiovascular disease: The Japan Public Health Center-Based Prospective (JPHC) study. Am J Clin Nutr. 110(6):1449–55.
   PubMed Web of Science ®Google Scholar
• Nickel JC, Gilling P, Tammela TL, Morrill B, Wilson TH, Rittmaster RS. 2011. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: The Enlarged Prostate International Comparator Study (EPICS). BJU Int. 108(3):388–94.
   PubMed Web of Science ®Google Scholar
• Pang SJ, Liu F, Shan TF, Gao SQ, Zhang ZH. 2009. Cultivation of the brown alga Sargassum horneri: Sexual reproduction and seedling production in tank culture under reduced solar irradiance in ambient temperature. J Appl Phycol. 21(4):413–22.
   Web of Science ®Google Scholar
• Preeprame S, Hayashi K, Lee JB, Sankawa U, Hayashi T. 2001. A novel antivirally active fucan sulfate derived from an edible brown alga, Sargassum horneri. Chem Pharm Bull (Tokyo). 49(4):484–85.
   PubMed Web of Science ®Google Scholar
• Sanjeewa KK, Fernando IP, Kim EA, Ahn G, Jee Y, Jeon YJ. 2017. Anti-inflammatory activity of a sulfated polysaccharide isolated from an enzymatic digest of brown seaweed Sargassum horneri in RAW 264.7 cells. Nutr Res Pract. 11(1):3–10.
   PubMed Web of Science ®Google Scholar
• Sanjeewa KKA, Jayawardena TU, Kim SY, Lee HG, Je JG, Jee Y, Jeon YJ. 2020. Sargassum horneri (Turner) inhibit urban particulate matter-induced inflammation in MH-S lung macrophages via blocking TLRs mediated NF-kappaB and MAPK activation. J Ethnopharmacol. 249:112363.
   PubMed Web of Science ®Google Scholar
• Sho H. 2001. History and characteristics of Okinawan longevity food. Asia Pac J Clin Nutr. 10(2):159–64.
   PubMed Web of Science ®Google Scholar
• Steers WD. 2001. 5alpha-reductase activity in the prostate. Urology. 58(6 Suppl 1):17–24; discussion 24.
   PubMedGoogle Scholar
• Tanguay S, Awde M, Brock G, Casey R, Kozak J, Lee J, Nickel JC, Saad F. 2009. Diagnosis and management of benign prostatic hyperplasia in primary care. Can Urol Assoc J. 3(3 Suppl 2):S92–100.
   PubMed Web of Science ®Google Scholar
• Thompson C B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267(5203):1456–62.
   PubMed Web of Science ®Google Scholar
• Thorpe A, Neal D. 2003. Benign prostatic hyperplasia. Lancet. 361(9366):1359–67.
   PubMed Web of Science ®Google Scholar
• Uygur MC, Gur E, Arik AI, Altug U, Erol D. 1998. Erectile dysfunction following treatments of benign prostatic hyperplasia: A prospective study. Andrologia. 30(1):5–10.
   PubMed Web of Science ®Google Scholar
• Yoshioka H, Ishida M, Nishi K, Oda H, Toyohara H, Sugahara T. 2014. Studies on anti-allergic activity of Sargassum horneri extract. J Funct Foods. 10:154–60.
   Web of Science ®Google Scholar
• Zhang J, Zhang M, Tang J, Yin G, Long Z, He L, Zhou C, Luo L, Qi L, Wang L. 2021. Animal models of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 24(1):49–57.
   PubMed Web of Science ®Google Scholar